The local medical landscape is buzzing with the emergence of retatrutide, a novel dual GIP and GLP-1 medication showing significant results in early trials for treating obesity. This therapy suggests a https://socialinplace.com/story7277191/retatrutide-australia-a-emerging-solution-for-weight-management